A state-of-the-art spinal injuries treatment technology introduced into Saudi Arabia by Abdul Latif Jameel has been approved by the Saudi Food and Drug Authority (SFDA).
The Medical Hybrid Assistive Limb (HAL®) helps to regenerate, improve, support and expand patients’ brain-neuro-physical functions. The device, which is already approved in the European Union and Japan, will first be available in Jeddah’s Abdul Latif Jameel Hospital, before being rolled out across Saudi Arabia.
Approval for the device follows Abdul Latif Jameel’s memorandum of understanding (MoU) with Japanese company Cyberdyne Inc earlier this year. The MoU was agreed during King Salman bin Abdulaziz Al Saud’s visit to Japan in March 2017, bringing new hope to patients across Saudi Arabia suffering from traumatic spinal injuries.
Dr Youssef Abdelrahman, Managing Director of Abdul Latif Jameel Hospital, said: “By bringing this state-of- the-art spinal treatment technology to Saudi Arabia, we are making sure patients who have suffered some of the most traumatic injuries will get the best possible care.”
“This approval from the Saudi Food and Drug Authority is welcome news, and means we are one step closer to making this technology available in Saudi Arabia.”
According to official government statistics, more than 13,000 people suffered traumatic spinal injuries in Saudi Arabia in 2015.